Vaccines are being tested against new variant of coronavirus

By  Gitanjali Mangal December 23rd 2020 10:26 AM

Vaccine makers, including BioNTech and Moderna, are testing their Covid vaccines against the new fast-spreading variant of the virus that is raging in Britain, and has become the latest challenge to curb the coronavirus pandemic. Virus close-up | Stock image | Colourbox Also Read | 6 passengers on Air-India's London-Delhi flight test COVID positive Coronavirus | Pfizer ends COVID-19 vaccine trial with 95% efficacy, to seek  emergency-use authorisation - The Hindu Ugur Sahin, chief executive of Germany's BioNTech, which with partner Pfizer took less than a year to get a vaccine approved, said on Tuesday he needed another two weeks to know if his shot could stop the mutant variant of the virus. Moderna expects immunity from its vaccine to protect against the variant and is performing more tests in coming weeks to confirm, the company stated. Indian Twitterati Has Funniest Take On COVID Vaccines That Are 90-95%  Effective, “5% Kahan Hai?” - RVCJ Media The mutation known as the B.1.1.7 lineage may be up to 70% more infectious and more of a concern for children. It has sown chaos in Britain, prompting a wave of travel bans that are disrupting trade with Europe and threatening to further isolate the island country. -PTC News

Related Post